Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Oncotarget|June 23, 2018
Effect of combined inhibition of p110 alpha PI3K isoform and STAT3 pathway in ovarian cancer platinum-based resistanceAugustin Le Naour, Renaud Mevel, Benoit Thibault, et al.
Gynecologic Oncology|April 6, 2011
Intraoperative fluorescence imaging of peritoneal dissemination of ovarian carcinomas. A preclinical studyEliane Mery, Eva Jouve, Stephanie Guillermet, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 16, 2015
Primary care physicians and oncologists are partners in cancer announcementMarie-Eve Rougé Bugat, Christelle Omnes, Cyrille Delpierre, et al.
Oncotarget|September 1, 2018
A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumorsJordi Rodon, Giuseppe Curigliano, Jean-Pierre Delord, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
RadioLigand Therapy with [<sup>177</sup>Lu]Lu-PSMA-617 for Salivary Gland Cancers: Literature Review and First Compassionate Use in FranceMarie Terroir, Chloé Lamesa, Mehdi Krim, et al.
Bulletin Du Cancer|October 5, 2012
[Compensable occupational disease and cancer: how to improve the recognition rate? "Cursus Laboris" Project in Midi-Pyrenees: feasibility study]Marie-Eve Rougé-Bugat, Fabrice Hérin, Sylvie Julien, et al.
British Journal of Clinical Pharmacology|November 29, 2013
How to manage intravenous vinflunine in cancer patients with renal impairment: results of a pharmacokinetic and tolerability phase I studyNicolas Isambert, Jean Pierre Delord, Jean Marc Tourani, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2018
Addressing heterogeneity in the design of phase II clinical trials in geriatric oncologyBastien Cabarrou, Patrick Sfumato, Loïc Mourey, et al.
Investigational New Drugs|September 25, 2014
A phase I open-label study of the safety, tolerability, and pharmacokinetics of pazopanib in combination with irinotecan and cetuximab for relapsed or refractory metastatic colorectal cancerJaafar Bennouna, Marion Deslandres, Helene Senellart, et al.
European Urology|February 27, 2023
Assessing Long-term Treatment Benefits Using Complementary Statistical Approaches: An In Silico Analysis of the Phase III Keynote-045 and Checkmate-214 Immune Checkpoint Inhibitor TrialsAna Cavillon, Damien Pouessel, Nadine Houédé, et al.
Pageof 23